Urine lipoarabinomannan testing in children with tuberculosis

Urine lipoarabinomannan testing in children with tuberculosis

Bibliographic Details
Main Author:	Ben J Marais
Format:	Article
Language:	English
Published:	Elsevier 2014-05-01
Series:	The Lancet Global Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214109X14702074

Similar Items

Sensitivity and specificity of the lipoarabinomannan test compared to GeneXpert in urine samples for tuberculosis diagnosis
by: Danni Irawan, et al.
Published: (2025-01-01)

Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV
by: Stephanie Bjerrum, et al.
Published: (2022-04-01)

The diagnostic accuracy of urine lipoarabinomannan test for tuberculosis screening in a South African correctional facility.
by: Yasmeen Hanifa, et al.
Published: (2015-01-01)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
by: Birgit Schramm, et al.
Published: (2021-01-01)

A sensitive urinary lipoarabinomannan test for tuberculosis.
by: Beston Hamasur, et al.
Published: (2015-01-01)

Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha
by: Bianca Sossen, et al.
Published: (2021-04-01)

Urine lipoarabinomannan concentrations among HIV-negative adults with pulmonary or extrapulmonary tuberculosis disease in Vietnam.
by: Nguyen B Hoa, et al.
Published: (2024-01-01)

Lateral flow urine lipoarabinomannan assay for extrapulmonary tuberculosis diagnosis in adults who are HIV-positive
by: Ni Nyoman Indirawati, et al.
Published: (2022-09-01)

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
by: Jason L Cantera, et al.
Published: (2022-01-01)

DIAGNOSTIC ACCURACY OF LIPOARABINOMANNAN DETECTION IN PLEURAL TUBERCULOSIS
by: A. Mohapatra, et al.
Published: (2023-05-01)

Diagnostic utility of urinary lipoarabinomannan in pulmonary tuberculosis
by: Sahar M.T Mourad, et al.
Published: (2019-01-01)

Lipoarabinomannan in Active and Passive Protection Against Tuberculosis
by: Margarida Correia-Neves, et al.
Published: (2019-09-01)

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.
by: Tobias Broger, et al.
Published: (2019-01-01)

Correction: Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis
Published: (2024-01-01)

Revisiting tuberculosis diagnosis: the prospect of urine lipoarabinomannan assay as a diagnostic tool in people living with human immunodeficiency virus
by: Ayodele Isaac Adedokun, et al.
Published: (2024-11-01)

Low tuberculosis treatment initiation after positive tuberculosis lipoarabinomannan results
by: Tinne Gils, et al.
Published: (2024-07-01)

Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
by: Shrikala Acharya, et al.
Published: (2022-01-01)

Clinical, radiological, and laboratory predictors of a positive urine lipoarabinomannan test in sputum-scarce and sputum-negative patients with HIV-associated tuberculosis in two Johannesburg hospitals
by: Lior Chernick, et al.
Published: (2021-07-01)

The opportunity and challenges associated with the development of cell-based biosensor for detection of urine mycobacterium lipoarabinomannan
by: Dian Ayu Eka Pitaloka, et al.
Published: (2024-02-01)

Diagnostic Efficiency of the Blood-Based Cepheid 3-Gene Host Response Test and Urine-Based Lipoarabinomannan for Active Tuberculosis Case Detection at a General Hospital in China
by: Ji Z, et al.
Published: (2024-10-01)

Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients
by: Danping Liu, et al.
Published: (2022-05-01)

Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine.
by: Prithwiraj De, et al.
Published: (2015-01-01)

Diagnostic accuracy of Lipoarabinomannan detection by lateral flow assay in pleural tuberculosis
by: Atish Mohapatra, et al.
Published: (2024-02-01)

A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
by: Hyun-Jin Shin, et al.
Published: (2017-01-01)

Diagnosis of genitourinary tuberculosis: detection of mycobacterial lipoarabinomannan and MPT-64 biomarkers within urine extracellular vesicles by nano-based immuno-PCR assay
by: Ekta Kamra, et al.
Published: (2023-07-01)

Test characteristics of urinary lipoarabinomannan and predictors of mortality among hospitalized HIV-infected tuberculosis suspects in Tanzania.
by: Elizabeth Talbot, et al.
Published: (2012-01-01)

Urinary lipoarabinomannan for diagnosis of Tuberculosis in an HIV-negative population: A scoping review
by: Omishka Hirachund, et al.
Published: (2024-12-01)

Correction to: Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala
by: Juan Ignacio García, et al.
Published: (2022-10-01)

Role of succinyl substituents in the mannose-capping of lipoarabinomannan and control of inflammation in Mycobacterium tuberculosis infection.
by: Zuzana Palčeková, et al.
Published: (2023-09-01)

Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.
by: Kara M Calhoun, et al.
Published: (2025-01-01)

Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics.
by: Shailja Jakhar, et al.
Published: (2021-01-01)

Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis.
by: Anita G Amin, et al.
Published: (2022-01-01)

Alere Determine-tuberculosis lipoarabinomannan positivity in disseminated non-tuberculous mycobacteria: An illustrative case series
by: Riana Greyling, et al.
Published: (2022-04-01)

Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis
by: Anita G. Amin, et al.
Published: (2022-01-01)

Real-world diagnostic accuracy of lipoarabinomannan in three non-sputum biospecimens for pulmonary tuberculosis diseaseResearch in context
by: Paul K. Drain, et al.
Published: (2024-10-01)

Diagnostic value of chemiluminescence for urinary lipoarabinomannan antigen assay in active tuberculosis: insights from a retrospective study
by: Luyi Huang, et al.
Published: (2023-12-01)

Applications of machine learning tools for ultra-sensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of tuberculosis
by: Yilun Huang, et al.
Published: (2022-01-01)

A Breakthrough in the Challenges of Tuberculosis Diagnosis: Lateral Flow Urine Lipoarabinomannan (LAM) Assay for the Diagnosis of Active Tuberculosis in a Subset of Human Immuno Deficiency Virus (HIV) Patients at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia
by: Ketema W, et al.
Published: (2022-08-01)

Collected Thoughts on Mycobacterial Lipoarabinomannan, a Cell Envelope Lipoglycan
by: Jordi B. Torrelles, et al.
Published: (2023-10-01)

Correction: Mycobacterium tuberculosis Lipoprotein LprG Binds Lipoarabinomannan and Determines Its Cell Envelope Localization to Control Phagolysosomal Fusion.
by: PLOS Pathogens Staff
Published: (2014-12-01)